Supplementary Tables S1-S4 from Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1: List of antibodies used in the mass cytometry panel Supplementary Table 2: Number of immune cells analysed by CYTOF in our cohort Supplementary Table 3: Demographic and clinical characteristics of the CyTOF UCLA cohort (n=27), the Total UCLA cohort (n=97) and the Total KEYNOTE-001 (n=495) of non-small cell lung cancer patients Supplementary Table 4: Cox's proportional hazards model for overall survival in NSCLC patients treated with pembrolizumab in KEYNOTE-001
Authors: Philippe Rochigneux, Aaron Lisberg, Alejandro Garcia, Samuel Granjeaud, Anne Madroszyk, Stéphane Fattori, Anthony Gonçalves, Raynier Devillier, Pauline Maby, Nassim Salem, Laurent Gorvel, Brice Chanez, Jaklin Gukasyan, James Carroll, Jonathan Goldman, Anne Sophie Chretien, Daniel Olive, Edward B. Garon
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361941633